Based on the genetic and clinical data of peripheral blood RNA in GSE63060 and GSE63061, the expression levels of Caspase 3 in the peripheral blood were significantly decreased in AD and MCI [33], which was consistent with plasma protein levels of Caspase 3 in our cohort. The gene discussed is CASP3; the disease is Alzheimer disease.